What You Should Know
The Reality Check: In HGP’s 20-year retrospective, the verdict is harsh: technology delivered on workflows but failed on economics. Since HGP’s founding, U.S. healthcare spending has doubled to $5.3 trillion, proving…
Continue Reading
What You Should Know
– Pomelo Care has closed a $92 million Series C funding round, propelling the company to a $1.7B valuation.
– After proving its virtual model can reduce preterm births by 37% and…
Continue Reading
Alexander Amatus, Business Development Lead at TherapyNearMe.com.au
For all the hype about AI “replacing therapists,” the more immediate and profound shift is happening somewhere far less glamorous: the intake process.
Across health systems, primary care physicians,…
Continue Reading
Loren Larsen, CEO and co-founder of Videra Health
The integration of AI into behavioral health has moved from experiment to expectation. The industry is rapidly finding its footing, moving past initial hype and learning from…
Continue Reading
What You Should Know:
– A new report from KLAS Research reveals that while healthcare AI adoption is surging in 2025, organizations are overwhelmingly favoring low-risk, high-efficiency tools like ambient speech and revenue cycle automation…
Continue Reading
Healthcare innovation appears very different depending on where it is built.In this episode, we sit down with Rami Ajjuri to discuss his career journey spanning startups and large corporations, as well as across various…
Continue Reading
What You Should Know:
– A new market survey from Carta Healthcare reveals that hospital leaders are overwhelmingly rejecting fully autonomous AI in favor of “hybrid intelligence” models that pair technology with clinical expertise.
– With…
Continue Reading
If the last two years were defined by the breathless hype of experimentation, 2026 marks the healthcare industry’s decisive transition from “flashy, one-off experiments” to “top-down programs designed for measurable impact”. Across the digital…
Continue Reading
TechBio vs. Biotech—what’s real, what’s hype, and how GenAI is actually changing the lab.In this interview, Kavya Sharman, PhD (Founder & Managing Partner, Phase Capital) breaks down the true differences between techbio and biotech,…
Continue Reading
